Structures by: Elhaïk J.
Total: 33
Bis(2,6-bis(3-(hydroxymethyl)pyrazol-1-yl)pyridine)iron(ii) diperchlorate, alpha polymorph
C26H26FeN10O4,2[ClO4]
CrystEngComm (2005) 7, 23 151
a=16.2700(6)Å b=11.3714(4)Å c=16.6040(6)Å
α=90.00° β=91.6986(16)° γ=90.00°
Bis(2,6-bis(3-(hydroxymethyl)pyrazol-1-yl)pyridine)iron(ii) diperchlorate, beta polymorph
C26H26FeN10O4,2[ClO4]
CrystEngComm (2005) 7, 23 151
a=20.1578(2)Å b=10.0249(1)Å c=16.2228(1)Å
α=90.00° β=108.3160(8)° γ=90.00°
Bis(2,6-bis(3-hydroxymethylpyrazol-1-yl)pyridine)iron(ii) diperchlorate acetonitrile solvate
C26H26FeN10O4,2[ClO4],0.75[C2H3N]
CrystEngComm (2005) 7, 23 151
a=22.8535(2)Å b=11.6789(1)Å c=27.9986(3)Å
α=90.00° β=107.6122(5)° γ=90.00°
Bis(2,6-bis(3-hydroxymethylpyrazol-1-yl)pyridine)iron(ii) diperchlorate acetonitrile solvate
C26H26FeN10O4,2[ClO4],0.75[C2H3N]
CrystEngComm (2005) 7, 23 151
a=22.4565(2)Å b=11.6040(1)Å c=27.9163(3)Å
α=90.00° β=107.3812(4)° γ=90.00°
Bis[2,6-di(pyrazol-1-yl)pyridine]iron(II) hemiiodide sesqui(triiodide)
[C22H18FeN10],I0.5,[I3]1.5
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=15.9084(3)Å b=13.6094(3)Å c=15.1155(2)Å
α=90.00° β=104.3473(8)° γ=90.00°
Bis[2,6-bis(3-methylpyrazol-1-yl)pyridine]iron(II) dihexafluoroantimonate
C26H26FeN10,2[F6Sb]
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=19.7007(4)Å b=11.1095(2)Å c=16.8557(2)Å
α=90.00° β=110.9156(6)° γ=90.00°
Bis[2,6-(3-methylpyrazol-1-yl)pyridine]iron(II) diperchlorate acetone solvate
C26H26FeN10,2[ClO4],C3H6O
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=23.1702(4)Å b=11.1910(2)Å c=28.3275(5)Å
α=90.00° β=107.0868(9)° γ=90.00°
Bis[2,6-(3-methylpyrazol-1-yl)pyridine]iron(II) diperchlorate acetone solvate
C26H26FeN10,2[ClO4],C3H6O
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=23.3113(3)Å b=11.2528(2)Å c=28.4066(4)Å
α=90.00° β=107.3076(8)° γ=90.00°
Bis[2,6-(3-methylpyrazol-1-yl)pyridine]iron(II) diperchlorate acetone solvate
C26H26FeN10,2[ClO4],C3H6O
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=22.7743(3)Å b=10.9586(2)Å c=28.4036(4)Å
α=90.00° β=106.1525(9)° γ=90.00°
Bis[2,6-(3-methylpyrazol-1-yl)pyridine]iron(II) diperchlorate acetone solvate
C26H26FeN10,2[ClO4],C3H6O
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=22.8777(2)Å b=11.0240(1)Å c=28.3914(3)Å
α=90.00° β=106.3318(7)° γ=90.00°
Bis[2,6-bis(3-methylpyrazol-1-yl)pyridine] ditetrafluoroborate tetrakis-acetonitrile solvate
C26H26FeN10,2[BF4],4[C2H3N]
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=11.6508(1)Å b=13.7476(1)Å c=26.4113(3)Å
α=90.00° β=90.00° γ=90.00°
Bis[2,6-bis(3-methylpyrazol-1-yl)pyridine] ditetrafluoroborate tetrakis-acetonitrile solvate
C26H26FeN10,2[BF4],4[C2H3N]
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=11.3871(1)Å b=13.6181(1)Å c=26.2355(3)Å
α=90.00° β=90.00° γ=90.00°
Bis[2,6-bis(3-methylpyrazol-1-yl)pyridine] ditetrafluoroborate tetrakis-acetonitrile solvate
C26H26FeN10,2[BF4],4[C2H3N]
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=11.2572(1)Å b=13.5578(1)Å c=26.1701(2)Å
α=90.00° β=90.00° γ=90.00°
Bis[2,6-bis(3-methylpyrazol-1-yl)pyridine] ditetrafluoroborate tetrakis-acetonitrile solvate
C26H26FeN10,2[BF4],4[C2H3N]
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=11.5476(1)Å b=13.6803(1)Å c=26.3236(2)Å
α=90.00° β=90.00° γ=90.00°
Bis[2,6-di(pyrazol-1-yl)pyridine]iron(II) bis[di(dicarbollido)cobalt(III)] nitromethane solvate (1/0.75)
C22H18FeN10,2[C4H22B18Co],0.75[CH3NO2]
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=37.297(2)Å b=10.5955(6)Å c=29.6321(17)Å
α=90.00° β=90.00° γ=90.00°
Bis[2,6-di(pyrazol-1-yl)pyridine]iron(II) bis[di(dicarbollido)cobalt(III)] nitromethane solvate (1/0.75)
C22H18FeN10,2[C4H22B18Co],0.75[CH3NO2]
Dalton transactions (Cambridge, England : 2003) (2006) 6 823-830
a=37.3516(19)Å b=10.5840(6)Å c=29.5118(15)Å
α=90.00° β=90.00° γ=90.00°
Bis(2,6-bis(4-methylpyrazol-1-yl)pyridine)iron(ii) diperchlorate (compound 6)
C26H26FeN10,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2006) 25 3058-3066
a=9.5865(14)Å b=9.5865(14)Å c=17.933(4)Å
α=90.00° β=90.00° γ=90.00°
Bis(2,6-bis(4-methylpyrazol-1-yl)pyridine)iron(ii) ditetrafluoroborate (compound 7)
C26H26FeN10,2[BF4],0.2[H2O]
Dalton transactions (Cambridge, England : 2003) (2006) 25 3058-3066
a=30.5415(9)Å b=16.5009(6)Å c=13.4070(5)Å
α=90.00° β=115.7118(15)° γ=90.00°
Bis(2,6-bis(4-methylpyrazol-1-yl)pyridine)iron(ii) diperchlorate (compound 6)
C26H26FeN10,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2006) 25 3058-3066
a=9.6000(19)Å b=9.6251(19)Å c=33.470(7)Å
α=90.00° β=90.00° γ=90.00°
Bis(2,6-di(pyrazol-1-yl)-4-(hydroxymethyl)pyridine)iron(ii) diperchlorate (compound 5)
C24H22FeN10O2,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2006) 25 3058-3066
a=12.269(3)Å b=12.216(2)Å c=20.572(4)Å
α=90.00° β=99.61(3)° γ=90.00°
Bis(2,6-di(pyrazol-1-yl)-4-(hydroxymethyl)pyridine)iron(ii) diperchlorate (compound 5)
C24H22FeN10O2,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2006) 25 3058-3066
a=11.969(2)Å b=11.986(2)Å c=20.094(4)Å
α=90.00° β=99.90(3)° γ=90.00°
Bis(2,6-di(pyrazol-1-yl)-4-(hydroxymethyl)pyridine)iron(ii) diperchlorate (compound 5)
C24H22FeN10O2,2(ClO4)
Dalton transactions (Cambridge, England : 2003) (2006) 25 3058-3066
a=12.052(2)Å b=12.043(2)Å c=20.105(4)Å
α=90.00° β=98.66(3)° γ=90.00°
Bis[2,6-bis(pyrazol-1-yl)pyrazine]iron(II) ditetrafluoroborate tris-nitromethane solvate
C20H16FeN12,2[BF4],3[CH3NO2]
Dalton Trans. (2003) 10 2053-2060
a=16.9138(2)Å b=8.3045(1)Å c=26.3119(4)Å
α=90.00° β=107.4285(4)° γ=90.00°
Bis[2,6-bis(pyrazol-1-yl)pyrazine]iron(II) ditetrafluoroborate tris-nitromethane solvate
C20H16FeN12,2[BF4],3[CH3NO2]
Dalton Trans. (2003) 10 2053-2060
a=16.5404(2)Å b=8.2833(1)Å c=25.8237(4)Å
α=90.00° β=108.2104(6)° γ=90.00°
Bis(2,6-bis(3-(2,4,6-trimethylphenyl)pyrazol-1- yl)pyrazine)iron(ii) ditetrafluoroborate pentakis-nitromethane solvate
C56H56B2F8FeN12,2[BF4],5[CH3NO2]
Dalton Trans. (2003) 10 2053-2060
a=15.1838(1)Å b=15.1838(1)Å c=24.9779(2)Å
α=90.00° β=90.00° γ=120.00°
Bis[2,6-bis(3,5-dimethylpyrazol-1-yl)pyrazine]iron(II) ditetrafluoroborate hemiacetone solvate
C28H32FeN12,2[BF4],0.5[C3H6O],0.1[H2O]
Dalton Trans. (2003) 10 2053-2060
a=11.3306(1)Å b=15.2392(2)Å c=40.5559(5)Å
α=90.00° β=92.8371(6)° γ=90.00°
Je52
C24H22FeN10O2,2(BF4)
Dalton transactions (Cambridge, England : 2003) (2004) 10 1516-1518
a=11.904(2)Å b=11.935(2)Å c=20.007(4)Å
α=90.00° β=99.71(3)° γ=90.00°
Je52
C24H22FeN10O2,2(BF4)
Dalton transactions (Cambridge, England : 2003) (2004) 10 1516-1518
a=11.974(2)Å b=12.001(2)Å c=20.014(4)Å
α=90.00° β=98.44(3)° γ=90.00°
C24H22FeN10O2,2(BF4)
C24H22FeN10O2,2(BF4)
Dalton transactions (Cambridge, England : 2003) (2004) 10 1516-1518
a=12.115(2)Å b=12.118(2)Å c=20.414(4)Å
α=90.00° β=99.53(3)° γ=90.00°
Holrc21
C50H80FeN5
Chemical communications (Cambridge, England) (2009) 34, 13 1760-1762
a=13.1565(17)Å b=19.524(2)Å c=18.978(2)Å
α=90.00° β=100.703(3)° γ=90.00°
C20Cl2FeN12O8
C20Cl2FeN12O8
Acta Crystallographica Section B (2004) 60, 1 41-45
a=8.4484(8)Å b=8.4322(8)Å c=19.404(2)Å
α=90.0° β=90.539(7)° γ=90.0°
HOLRC04
C78H112Fe2N10,2(CH2Cl2)
Journal of the American Chemical Society (2008) 130, 6074-6075
a=14.2681(16)Å b=18.409(2)Å c=14.5166(16)Å
α=90.00° β=90.204(2)° γ=90.00°
Holrc02
C90H136Fe2N10,2(C6D6)
Journal of the American Chemical Society (2008) 130, 6074-6075
a=24.789(3)Å b=24.031(3)Å c=15.525(2)Å
α=90.00° β=90.00° γ=90.00°